Does the Loudness Dependence of Auditory Evoked Potential Predict Response to Selective Serotonin Reuptake Inhibitors?: A Meta-analysis

키워드

참고문헌 (31)

1. Shih-Hsien Lin, "Serotonin and Mental Disorders: A Concise Review on Molecular Neuroimaging Evidence", Clinical Psychopharmacology and Neuroscience, 12(3), pp.196~202 (2014), 대한정신약물학회
2. Naughton M, "A review of the role of serotonin receptors in psychiatric disorders", Hum Psychopharmacol, 15, pp.397~415 (2000)
3. Vaswani M, "Role of selective serotonin reuptake inhibitors in psychiatric disorders : a comprehensive review", Prog Neuropsychopharmacol Biol Psychiatry, 27, pp.85~102 (2003)
4. Baldwin DS, "Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder : a revision of the 2005 guidelines from the British Association for Psychopharmacology", J Psychopharmacol, 28, pp.403~439 (2014)
5. Kennedy SH, "Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments", Can J Psychiatry 2001;46 Suppl, 46(Suppl 1), pp.38S~58S (2001)
6. Charney DS, "Neurobiology of mental illness" (2013), Oxford University Press
7. Hegerl U, "Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?", J Affect Disord, 62, pp.93~100 (2001)
8. O'Neill BV, "The loudness dependence of the auditory evoked potential(LDAEP)as an in vivo biomarker of central serotonergic function in humans : rationale, evaluation and review of findings", Hum Psychopharmacol, 23, pp.355~370 (2008)
9. Papakostas GI, "Treatment of SSRI-resistant depression : a meta-analysis comparing within-versus acrossclass switches", Biol Psychiatry, 63, pp.699~704 (2008)
10. Perlman K, "A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder", J Affect Disord, 243, pp.503~515 (2019)
11. Pogarell O, "Prediction of clinical response to antidepressants in patients with depression : neurophysiology in clinical practice", Clin EEG Neurosci, 38, pp.74~77 (2007)
12. Lee BH, "Prediction of long-term treatment response to selective serotonin reuptake inhibitors(SSRIs)using scalp and source loudness dependence of auditory evoked potentials(LDAEP)analysis in patients with major depressive disorder", Int J Mol Sci, 16, pp.6251~6265 (2015)
13. Park YM, "The loudness dependence of the auditory evoked potential(LDAEP)as a predictor of the response to escitalopram in patients with generalized anxiety disorder", Psychopharmacology(Berl), 213, pp.625~632 (2011)
14. Landis JR, "The measurement of observer agreement for categorical data", Biometrics, 33, pp.159~174 (1977)
15. Cohen J, "A power primer", Psychol Bull, 112, pp.155~159 (1992)
16. Viechtbauer W, "Conducting meta-analyses in R with the metafor package", J Stat Softw, 36, pp.1~48 (2010)
17. Juckel G, "Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder", J Clin Psychiatry, 68, pp.1206~1212 (2007)
18. Mulert C, "Prediction of treatment response in major depression : integration of concepts", J Affect Disord, 98, pp.215~225 (2007)
19. Lee TW, "Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression", J Psychiatry Neurosci, 30, pp.202~205 (2005)
20. Gallinat J, "The loudness dependency of the auditory evoked N1", P2-component as a predictor of the acute SSRI response in depression, 2000, pp.148, 404~411
21. Mulert C, "Comparison between the analysis of the loudness dependency of the auditory N1", P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression, 2002, pp.113, 1566~1572
22. Mennin DS, "Is generalized anxiety disorder an anxiety or mood disorder? Considering multiple factors as we ponder the fate of GAD", Depress Anxiety, 25, pp.289~299 (2008)
23. Hitz K, "Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials(LDAEP)in humans", Psychopharmacology(Berl), 221, pp.389~396 (2012)
24. O'Neill BV, "High-dose glycine inhibits the loudness dependence of the auditory evoked potential(LDAEP)in healthy humans", Psychopharmacology(Berl), 195, pp.85~93 (2007)
25. Lee S, "Association of the loudness dependence of auditory evoked potentials with clinical changes to repetitive transcranial magnetic stimulation in patients with depression", J Affect Disord, 238, pp.451~457 (2018)
26. Trippe J, "burst and conventional low-frequency rTMS differentially affect GABAergic neurotransmission in the rat cortex", Exp Brain Res, 199, pp.411~421 (2009)
27. Pogarell O, "Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine", Psychiatry Res, 156, pp.251~255 (2007)
28. Baeken C, "The impact of HF-rTMS treatment on serotonin(2A)receptors in unipolar melancholic depression", Brain Stimul, 4, pp.104~111 (2011)
29. Moisset X, "From pulses to pain relief : an update on the mechanisms of rTMS-induced analgesic effects", Eur J Pain, 20, pp.689~700 (2016)
30. Cohen ZD, "Treatment selection in depression", Annu Rev Clin Psychol, 14, pp.209~236 (2018)
31. Huedo-Medina TB, "Assessing heterogeneity in meta-analysis: Q statistic or I2index?", Psychol Methods, 11, pp.193~206 (2006)

관련 논문AI추천